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ABSTRACT
Objective To assess the effect of lateral wedge insoles
compared with flat control insoles on improving
symptoms and slowing structural disease progression in
medial knee osteoarthritis.
Design Randomised controlled trial.
Setting Community in Melbourne, Australia.
Participants200peopleaged50ormorewithclinicaland
radiographic diagnosis of mild to moderately severe
medial knee osteoarthritis.
Interventions Full length 5 degree lateral wedged insoles
or flat control insoles worn inside the shoes daily for
12 months.
Main outcome measures Primary symptomatic outcome
waschangeinoverallkneepain(pastweek)measuredon
an 11 point numerical rating scale. Primary structural
outcome was change in volume of medial tibial cartilage
from magnetic resonance imaging scans. Secondary
clinical outcomes included changes in measures of pain,
function, stiffness, and health related quality of life.
Secondary structural outcomes included progression of
medial cartilage defects and bone marrow lesions.
Results Between group differences did not differ
significantlyfortheprimaryoutcomesofchangeinoverall
pain (−0.3 points, 95% confidence intervals −1.0 to 0.3)
and change in medial tibial cartilage volume (−0.4 mm
3,
95% confidence interval −15.4 to 14.6), and confidence
intervals did not include minimal clinically important
differences. None of the changes in secondary outcomes
showed differences between groups.
Conclusion Lateral wedge insoles worn for 12 months
providednosymptomaticorstructuralbenefitscompared
with flat control insoles.
Trial registration Australian New Zealand Clinical Trials
Registry ACTR12605000503628 and ClinicalTrials.gov
NCT00415259.
INTRODUCTION
Knee osteoarthritis, which most commonly affects the
medial compartment, is a chronic joint disorder that
imposesamajorhealthcareburden.
1Asnocureexists,
traditional management aims to reduce pain, improve
function, and enhance quality of life while minimising
the adverse effects of therapy. Non-drug conservative
interventions are considered the first line approach to
osteoarthritis management.
2 However, given that a
substantial proportion of patients with knee osteoar-
thritis experience progression of structural disease,
3
contemporary management also aims to reduce struc-
tural deterioration. Research since early 2000 shows
that increased medial knee joint loading is an impor-
tant risk factor for disease progression of medial
osteoarthritis.
4 Thus non-surgical treatments that
reduce medial load on the knee warrant investigation.
Lateralwedgeshoeinsolesareaninexpensivereadily
availabletreatmentthathasbeenshowntoreducemed-
ial knee load.
56Wedged insoles are recommended by
13of14internationalguidelinesforkneeosteoarthritis
2;
however, the limited research available has failed to
show any significant impact of lateral wedge insoles on
the symptoms of osteoarthritis. The few randomised
controlled trialsthat havebeen done arelimited by fac-
torssuchassmallsamplesize,shortinterventionperiod,
use of suboptimal lateral wedge design, or a heteroge-
neous cohort with osteoarthritis.
7-10 Importantly, only
one trial has evaluated the effects of lateral wedge
insoles on joint structure.
9 The non-significant finding
in this study may be related to the use of radiology to
measure structural change, which is less sensitive than
magnetic resonance imaging,
1112 or to the use of heel
wedges, which do not reduce medial load as much as
full length wedges.
13
We carried out a randomised controlled trial to
assess the efficacy of lateral wedge insoles compared
with control insoles worn daily for 12 months on
improving symptoms and slowing structural disease
progression in people with medial knee osteoarthritis.
METHODS
We recruited participants from the community
through advertisements in local clubs and the print
and radio media in metropolitan Melbourne, Austra-
lia,betweenMay2005andJuly2008.Inclusioncriteria
wereage50yearsormore,averagekneepainonwalk-
ing more than 3 on an 11 point scale (0=no pain;
10=worst pain possible) at telephone screening, pain
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of osteophytes in the medial compartment or medial
joint space narrowing on an x ray film,
14 and radio-
logical knee alignment of 185 degrees or less (corre-
sponding to a mechanical axis angle of ≤182 degrees
and indicating neutral to varus (bow leg) knee align-
ment on an x ray film of the whole leg).
15 All partici-
pants provided written informed consent.
Exclusion criteria were questionable or advanced
radiographic knee osteoarthritis (Kellgren and Lawr-
ence grades 1 and 4),
16 predominant patellofemoral
joint symptoms on clinical examination (location of
pain, pain provoking activities, tenderness on palpa-
tion, and pain during mobilisation of the patellar),
17
knee surgery or intra-articular corticosteroid injection
within six months, current or past (within four weeks)
use of oral corticosteroids, systemic arthritic condi-
tions, history of knee arthroplasty or osteotomy,
othermusculoskeletalorneurologicalconditionaffect-
inglegfunction,diseaseoftheankleorfootprecluding
the use of insoles, use of foot orthotics within the past
six months, usual footwear unable to accommodate
insoles, contraindications to magnetic resonance ima-
ging,planningtostartothertreatmentforkneeosteoar-
thritis, and regular use of a gait aid.
Procedures
We carried out a double blind randomised controlled
trial over 12 months, the methodology of which has
been described previously.
18 Potential participants
underwent telephone screening followed by standar-
dised semiflexed standing posteroanterior knee radio-
logy, to assess the severity of knee osteoarthritis and
knee joint alignment. A physiotherapist or medical
practitioner and a podiatrist then carried out a screen-
ingclinicalexamination.Participantswerestratifiedby
disease severity (Kellgren and Lawrence grades 2 and
3
16) and sex and randomly allocated in permuted
blocks of 6 to 12 to either the lateral wedge insole or
the control insole group. An independent investigator
used a computer program to generate the randomisa-
tionsequenceapriori.Allocationwassealedinopaque
andconsecutivelynumberedenvelopesheldcentrally.
Envelopes were opened sequentially by an indepen-
dent person. Participants were informed that two
types of insoles were being compared but the insoles
and study hypotheses were not described.
Interventions
Participants wore the insoles bilaterally in their own
shoes every day. They were provided with two pairs
of insoles, which were replaced every four months.
The lateral wedge (5 degrees) insoles were made of
high density ethyl vinyl acetate (similar to the midsole
in a running shoe) and were wedged along the lateral
border of the foot (Foot Function, New Zealand, see
webextra).Wechosea5degreewedgebecausegreater
wedgingislesslikelytobetoleratedbythewearer
6and
is difficult to accommodate within a normal shoe. The
control insoles were made of easily compressible low
density ethyl vinyl acetate but with no wedging (Foot
Function, New Zealand).
Outcome measures
A blinded examiner assessed the participants at base-
line and 12 months. In participants with bilateral knee
osteoarthritis the most symptomatic eligible knee was
assessed. Baseline demographic information was col-
lectedandparticipantsratedtheirexpectationofaben-
eficial effect with insole treatment on an ordinal scale
from 1 to 5 (0=no effect at all, 5=complete recovery),
with higher scores indicating higher expectations.
Symptomatic measures
The primary symptomatic measure was overall aver-
age knee pain (past week) using an 11 point numerical
ratingscale(0=nopain,10=worstpainpossible).
19This
has well accepted clinimetric properties and is widely
used and recommended for clinical trials on knee
osteoarthritis.
19-22
Secondary symptomatic measures included pain on
walking (measured on the 11 point scale), pain, stiff-
ness, and physical function subscales of the Western
Ontario and McMaster Universities osteoarthritis
index,
23 assessment of quality of life instrument,
24 and
patientperceivedglobalchangeinpainandinphysical
function (compared with baseline) measured on a 5
point ordinal scale and dichotomised into improve-
ment(slightlybetterandmuchbetter)andnoimprove-
ment(muchworse,slightlyworse,andnochange).We
also measured levels of physical activity using two
methods: the physical activity scale for the elderly
questionnaire, with higher scores indicating greater
physical activity,
25 and the average number of steps
taken per day, as measured by a pedometer (KH-005;
Omron Healthcare, Japan), worn for one week on two
occasions.Participants recordeduseof and discomfort
withinsolesdailyinalogbook(returnedonamonthly
basis) and using an 11 point numerical rating scale at
follow-up. Adverse events and cointerventions were
recorded in the log book and by open probe question-
ing at follow-up.
Structural measures
The primary structural outcome measure was the
volume of cartilage in the medial tibial compartment
on magnetic resonance imaging.Images of the knee in
the sagittal plane were obtained on a T1 weighted
wholebodyunitaspreviouslydescribed.
26Wedefined
thevolumeofthemedialtibialcartilageplatebymanu-
ally drawing disarticulation contours around the carti-
lage boundary on each section. Data were resampled
by bilinear and cubic interpolation (area of 312 and
312 μm and 1.5 mm thickness, continuous sections)
for final three dimensional rendering. We determined
thevolumeofmedialtibialcartilageplatebysumming
the pertinent voxels within the resultant binary
volume.Twotrainedblindedobserversindependently
determined the measurements. The coefficient of var-
iationforthecartilagevolumemeasurewas3.4%.
27To
controlmedialtibialcartilagevolumeforbonesize,we
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plateaubycreatinganisotropicvolumefromtheinput
image, which was reformatted in the axial plane, using
the software program Osiris. The area was directly
measured from this axial image as described
previously.
28 By subtracting the follow-up volume
from baseline volume and dividing by time between
scans we determined the annual change in tibial carti-
lagevolume.Thiswasalsoexpressedasapercentageof
initial volume.
Secondary structural outcomes included cartilage
defects, graded with a classification system on a 0 to 4
scale, as described previously
2930 for medial tibial and
femoral compartments: grade 0, normal cartilage;
grade 1, focal blistering and intracartilaginous low
signalintensity area withan intact surface and bottom;
grade2,irregularitiesonthesurfaceorbottomandloss
of thickness of less than 50%; grade 3, deep ulceration
with loss of thickness of more than 50%; and grade 4,
fullthicknesscartilagewearwithexposureofsubchon-
dral bone. The measurement was carried out by one
trainedobserver,whomeasuredallimagesinduplicate
on separate occasions. Progression of medial tibiofe-
moral cartilage defects was determined if the cartilage
defect score increased by at least 1 from baseline to
follow-up in the medial tibial or medial femoral com-
partment.
Bone marrow lesions were defined as areas of
increased signal intensity adjacent to subcortical bone
present in either the medial distal femur or the proxi-
mal tibia, and their size was graded on a 0 to 2 scale as
described previously from coronal T2 fat saturated
images
31: grade 0, absence of a lesion; grade 1, lesion
encompassed up to 25% of the width of the tibial or
femoral cartilage being examined from coronal
images; and grade 2, lesion encompassed more than
25% of the width of the tibial or femoral cartilage
being examined from coronal images. We also
recordedthenumberofslicesthebonemarrowlesions
encompassed. To provide the medial tibiofemoral
bone marrow lesion we multiplied the bone marrow
lesiongrade(0-2)bythenumberofslicesforthemedial
femoral and medial tibial compartment separately,
which was then summed. Progression of bone marrow
lesions was defined if there was an increase in bone
marrow lesion score of 1 or more over the period—
that is, follow-up tibiofemoral bone marrow lesion
score minus the baseline lesion score of 1 or more.
Thisscoringsystemisavalidmeasureofbonemarrow
lesions as it has been shown to be sensitive to change
and to detect clinically important outcomes.
3233
Magnetic resonance imaging machines
We used two different magnetic resonance imaging
machines; initially a Philips machine (Eindhoven,
Netherlands) followed by a GE machine (Signa
AdvantageHiSpeedGEMedicalSystems,Milwaukee,
WI), owing to decommissioning of the Philips
machine.Intotal,117(68%)participantswerescanned
on the same machine at baseline and follow-up (102
had both scans on the Philips machine and 15 had
bothscansonthe GEmachine),whereas54 (32%)par-
ticipants were scanned on the Philips machine at base-
line and the GE machine at follow-up.
A validity study confirmed no systematic difference
with change of machines. Fifteen participants under-
went scans of one knee using both machines. The
mean medial tibial cartilage volume as measured on
the Philips and GE machines was 1706.3 (SD 361.2)
mm
3 and 1719.3 (SD 394.4) mm
3, respectively
(P>0.05). The intraclass correlation coefficient from a
onewayanalysisofvariancewas0.98(95%confidence
interval 0.95 to 0.99), showing excellent absolute
agreement between measures. A Bland-Altman plot
of the difference (Philips-GE machine) versus average
measurements showed the mean to be −13 mm
3, with
Allocated to flat control insoles (n=97) Allocated to wedge insoles (n=103)
Assessed for eligibility by telephone (n=1923)
Assessed for eligibility by radiography (n=486)
Completed follow-up (n=90)
Completed follow-up magnetic resonance
  imaging (n=88)
Completed follow-up questionnaires (n=90)
Did not complete follow-up (n=7):
  Refused (n=3)
  Knee replacement (n=2)
  Lost contact (n=1)
  Could not make appointments (n=1)
Completed follow-up (n=89)
Completed follow-up magnetic resonance
  imaging (n=84)
Completed follow-up questionnaires (n=87)
Did not complete follow-up (n=14):
  Refused magnetic resonance imaging (n=7)
  Lost contact (n=3)
  Illness (n=1)
  Knee replacement (n=1)
  Could not make appointments (n=1)
  Moved overseas (n=1)
Excluded (n=1437):
  Inappropriate knee symptoms (n=517)
  Unknown (n=194)
  Unable to attend (n=122)
  Other health problem (n=122)
  Wears insoles (n=111)
  Total knee or hip replacement (n=77)
  Not interested (n=69)
  Body mass index >34 (n=53)
  Other treatment (n=43)
  Systemic arthritis (n=39)
  Contraindication to magnetic resonance imaging (n=27)
  Age <50 (n=25)
  Uses gait aid (n=21)
  Other (n=9)
  High tibial osteotomy (n=8)
Excluded (n=277):
  Did not meet inclusion criteria (n=259)
  Refused to participate (n=18)
Enrolment
Allocation
Analysed (n=97)
Excluded from analysis (n=0)
Analysed (n=103)
Excluded from analysis (n=0)
Analysis
Intervention phase
Assessed for eligibility by physical screening (n=209)
Did not meet inclusion criteria (n=9)
Randomised (n=200)
Follow-up
Full time, daily insole use for 12 months
Fig 1 | Flow of participants through trial
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3.Thestan-
dard error of measurement was calculated as
49.3mm
3.Tocomparebetweenmachinerepeatability
withwithinmachinerepeatability, 12ofthese15parti-
cipants underwent a second measurement on the Phi-
lips machine, yielding a standard error of
measurement of 33.3 mm
3, with 95% limits of agree-
mentof−75.6to106.5mm
3.Theselimitsindicatecom-
parable but slightly less reproducibility between
machines than within machines.
Sample size
Overall, 126 participants were required to detect a
minimal clinically important difference of 1.5 for
change in pain between groups,
34 assuming a standard
deviation of 3 (based on previous data
3536), with 80%
power at a 5% significance level. We have shown that
the mean rate of tibial cartilage loss is 5.3% (SD 5.2%)
per year in knee osteoarthritis.
27 Data suggest that a
clinicallybeneficialoutcomewithlateralwedgeinsoles
wouldbetoreducetherateofcartilagelosstolessthan
3% per annum, as this is associated with a reduced risk
forarthroplastywithinfouryears.
37Thuswerequireda
minimum of 160 participants to detect a difference of
2.3% between groups, with 80% power at a 5% signifi-
cance level. We increased the sample size to 200 to
account for dropouts and to allow for at least 80%
power for both the primary outcomes.
Statistical analysis
A blinded statistician carried out the analysis, which
was by intention to treat. All analyses were done
using Stata (Version 11), and we considered P values
of less than 0.05 to be significant. For continuous out-
come measures we used linear regression modelling
adjustedforbaselinevaluesoftheoutcometocompare
differencesin meanchange(baselineminusfollow-up)
betweengroups.Resultsarepresentedasestimateddif-
ferenceswith95%confidenceintervals.Theanalysisof
change in medial cartilage volume was repeated with
furtheradjustmentforage,sex,bodymassindex,med-
ial tibial bone size, and magnetic resonance imaging
machine. We summarised the total medial bone mar-
row lesion scores as the median change from baseline
(interquartile range) and compared scores between
groups using the difference in median change. Using
logbinomialregressionwecomparedglobalchangein
pain and in physical function and progression of carti-
lage defects between groups. Results are presented as
relative risks with 95% confidence intervals. We used
bootstrap confidence intervals based on 5000 replica-
tions to compare changes in the size of bone marrow
lesions.
To account for missing data (31/400 pain measures
and 29/400 medial tibial cartilage volume measures,
7% of total baseline and follow-up dataset for each
measure)wecarriedoutasensitivityanalysisusingsin-
gle mean imputation of missing baseline measures
38
and multiple imputation of missing follow-up mea-
sures, assumingdata are missingat random and follow
a multivariate
39 normal distribution. As results were
unchanged we present complete case analyses.
We undertook a second sensitivity analysis to esti-
mate the between group difference that would occur
ifallparticipantsadheredcompletelytotheirallocated
treatment.Fortheseanalysesadherencewasmeasured
by the number of days the insoles were worn as
reportedinthelogbooks.Attestwasusedtocompare
adherence between the groups. For each of the two
primary outcomes we used a two stage least squares
instrumental variables approach.
40 This involved a
regression model of the outcome measure adjusted
for the baseline value and adherence, and a second
regressionmodelofadherencewasadjustedforrando-
mised group. The two regression models were fitted
simultaneously and we estimated the effect of the lat-
eral wedged insoles under full adherence.
RESULTS
Ofthe1923volunteers,1437(74.7%)wereineligibleor
did not wish to participate (fig 1). In total 200 partici-
pants (103 lateral wedge insoles, 97 control insoles)
were randomised and 179 (89 lateral wedge insoles,
90 control insoles; 90%) completed the trial. Baseline
descriptive characteristics of participants indicated no
Table 1 |Baseline characteristics of participants, by treatment group. Values are numbers
(percentages) unless stated otherwise
Variable Wedge insoles (n=103) Control insoles (n=97)
Mean (SD) age (years) 63.3 (8.1) 65.0 (7.9)
Women 62 (60) 56 (58)
Mean (SD) body mass index 28.1 (4.2) 30.4 (5.6)
Mean (SD) symptom duration (years) 7.1 (7.9) 7.5 (7.7)
Duration of symptoms (years):
<1 11 (11) 5 (5)
1t o< 5 4 2( 4 1 ) 4 0( 4 1 )
5 to <10 21 (21) 23 (24)
≥10 28 (28) 29 (30)
Unilateral symptoms 33 (32) 37 (38)
Radiographic disease severity:
Grade 2 49 (48) 46 (47)
Grade 3 54 (52) 51 (53)
Location of osteophytes:
Medial compartment 103 (100) 93 (96)
Lateral compartment 23 (22) 21 (22)
Location of joint space narrowing:
Medial compartment 99 (96) 96 (99)
Lateral compartment 80 (78) 77 (79)
Mean (SD) anatomical alignment (degrees) 181 (3) 181 (3)
Current drug use:
Analgesia 9 (9) 13 (13)
Non-steroidal anti-inflammatory drugs 15 (15) 26 (27)
Cyclo-oxygenase-2 inhibitors 2 (2) 4 (4)
Glucosamine products 34 (33) 30 (31)
Past treatments:
Arthroscopy 45 (44) 43 (44)
Physiotherapy 16 (16) 11 (11)
Exercise 3 (3) 2 (2)
Cortisone injection 3 (3) 3 (3)
Not all numbers add up to totals owing to missing data.
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the 21 participants lost to follow-up were similar to
those completing the study (data not shown). The par-
ticipants’ expectationof treatment outcomeswas simi-
lar between groups (P=0.51), with 54% (n=97) of 180
participants who provided these data expecting
moderate improvement, 25% (n=45) expecting large
improvement, and 2% (n=4) expecting complete
recovery.
Outcome measures
The between group difference for the primary out-
come of change in overall average pain did not differ
significantly (−0.3 points, 95% confidence interval,
−1.0 to 0.3), table 2). Both groups showed small
mean reductions in pain over time, but these reduc-
tions were smaller than the minimal clinically impor-
tantdifference.
34Thebetweengroupdifferenceforthe
primary outcome of change in medial tibial cartilage
volume over 12 months did not differ significantly
whenexpressedinabsoluteterms(−0.4mm
3,95%con-
fidence interval −15.4 to 14.6, table 2) or when
expressed as the percentage change. Lateral wedge
insoles were associated with a mean reduction of
3.0% (SD 3.1%) in cartilage volume compared with
2.8% (3.5%) for control insoles (mean difference
0.2%,95%confidenceinterval−0.8%to1.2%).Further
adjustment for covariates (sex, age, body mass index,
bone size, and magnetic resonance imaging machine)
resulted in an estimate of between group difference in
change in medial tibial cartilage volume of −0.7 mm
3
(95% confidence interval −16.7 to 15.4).
Theprimaryresultsdidnotchangeunderahypothe-
ticalscenarioofcompleteadherencetotreatment(allo-
catedinsolesworndailyforayearbyeverypatient).In
this scenario, the between group difference in mean
change in average pain was estimated as −1.6 points
(95% confidence interval −5.6 to 2.5, P=0.444), and
for change in medial tibial cartilage volume was esti-
matedas−25.5mg
3(95%confidenceinterval−130.6to
80.0, P=0.634).
Lateral wedge insoles had similar effects to control
insolesacrossallsecondaryoutcomemeasures(tables 2
and3).Althoughmostparticipantsreportedimproved
pain and function after treatment there was no differ-
encebetweengroupsforglobalchangescores(table 3).
Changes in secondary structural outcomes were also
similar between groups (table 3). A relatively small
number of participants showed progression of medial
tibial or femoral cartilage defects over 12 months.
Changes in the size of bone marrow lesions were also
similarbetweengroups,withthemedianchangebeing
0 (interquartile range −2-3) for the lateral wedge insole
groupand0(−2-2)forthecontrolinsolegroup,withan
estimateddifferenceinmedianchangesof0(95%boot-
strap confidence interval −0.31 to 0.31).
Adherence, insole comfort, adverse events, and
cointerventions
Log book completion rates were 69% for the lateral
wedge insole group and 73% for the control insole
group. The mean duration of daily insole use was sig-
nificantly lower in the lateral wedge insole group than
inthecontrolinsolegroup(6.8(SD4.3)hoursperdayv
Table 2 |Difference in symptomatic and structural changes within and between insole groups from baseline to 12 months’ follow-up in participants with
medial knee osteoarthritis
Outcome
Mean (SD) week 0 Mean (SD) week 52
Mean (SD) difference within
groups (week 0−week 52)
Mean (95% CI)
difference
between groups
(week 0−week 52)*
Wedge insoles
(n=103)
Control insoles
(n=97)
Wedgeinsoles
(n=89)
Control insoles
(n=90)
Wedge
insoles
Control
insoles
Wedge insoles
−control insoles
Secondary measures
Primary outcomes
Average pain† (0-10) 4.0 (2.1) 4.3 (1.9) 3.1 (2.1) 3.1 (2.3) 0.9 (2.1) 1.3 (2.4) −0.3 (−1.0 to 0.3)
Medial tibial cartilage
volume (mm
3)
1550 (452) 1520 (439) 1513 (480) 1483 (432) 43 (45) 43 (53) −0.4 (−15.4 to 14.6)
Pain on walking† (0-10) 4.2 (2.2) 4.3 (1.9) 3.2 (2.1) 3.0 (2.5) 0.9 (2.2) 1.4 (2.6) −0.3 (−1.0 to 0.4)
WOMAC‡:
Pain (0-20) 7.1 (3.0) 7.2 (2.9) 6.4 (3.3) 6.2 (3.2) 0.7 (2.7) 1.2 (3.1) −0.4 (−1.2 to 0.4)
Function (0-68) 23.7 (12.2) 23.6 (10.9) 20.8 (12.2) 20.1 (11.6) 3.1 (9.0) 4.0 (11.2) −0.7 (−3.6 to 2.2)
Stiffness (0-8) 4 (2) 4 (1) 3 (2) 3 (2) 0.4 (1.4) 0.6 (1.7) −0.3 (−0.7 to 0.2)
Healthrelatedqualityof
life (−0.04-1.00)§
0.7 (0.2) 0.7 (0.2) 0.7 (0.2) 0.7 (0.2) −0.02 (0.11) −0.01 (0.13) −0.01 (−0.05 to 0.02)
Physical activity scale
for elderly (0-400)
182 (81) 162 (68) 167 (83) 167 (88) 16 (77) 1 (83) 7.8 (−15.4 to 30.9)
No of daily steps 7908 (3712) 7562 (3593) 8059 (4946) 6688 (4106) −14 (3189) 673 (3217) −797.9 (−1966 to 370.2)
WOMAC=Western Ontario and McMaster Universities osteoarthritis index.
Differences within and between groups concern only participants with baseline and follow-up data.
*Adjusted for baseline value of variable.
†Assessed using numerical rating scale, with higher scores indicating worse pain.
‡Higher scores indicating worse pain, function, and stiffness.
§Assessed using assessment of quality of life instrument, with higher scores indicating better quality of life.
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sistent over the study (fig 2). Self reported adherence
with insole use was also lower in the lateral wedge
insole group, reflecting log book data (table 4).
Moreparticipantsreportedproblemswiththelateral
wedge insoles (42/89, 47%) than with the control
insoles (21/90, 23%, table 4). Lateral wedge insoles
were more likely to be associated with back and foot
painandtobedifficulttofitintoshoesthanthecontrol
insoles. Lateral wedge insoles were also rated as less
comfortable. Around half of the participants stated
that the lateral wedge insole was associated with some
degree of discomfort compared with 30% of partici-
pants in the control group. Severe or very severe dis-
comfortwasratedby7(10%)inthelateralwedgeinsole
group compared with 1 (1%) in the control insole
group.
Use of analgesic, non-steroidal anti-inflammatory
drugs and glucosamine preparations was similar
between groups (table 4). Cointerventions were
reported by 17/89 (19%) participants in the lateral
wedge insole group and 14/90 (16%) participants in
the control insole group (table 4), with a similar num-
ber and type of cointerventions across groups.
DISCUSSION
Our randomised controlled trial showed that lateral
wedge insoles compared with flat control insoles
worn for 12 months provided no additional benefit in
alleviatingsymptomsorslowingdiseaseprogressionin
olderadults(≥50years)withmildtomoderatelysevere
medial knee osteoarthritis. Our results do not support
therecommendationsofclinicalguidelinesadvocating
the use of lateral wedge insoles for the management of
medial knee osteoarthritis.
2
Explanation of results
Most of our participants had varus knee alignment, a
factor known to increase the risk of structural disease
progression
41 and thus rendering our cohort an
osteoarthritis subgroup ideally suited to disease mod-
ifying interventions. Our lateral wedge insoles had no
significant effect on structural change over time. Simi-
lar annual loss of medial tibial cartilage volume was
observed in both treatment groups (2.8-3.0%) and this
is within the range of annual cartilage loss in knee
osteoarthritis reported by longitudinal studies.
42 Our
non-significant findings occurred even though we
used lateral wedge insoles known to reduce medial
knee load during walking.
5 Specifically, we have pre-
viously reported a significant reduction of 5.4% (SD
5.2%) in the knee adduction moment during walking
(a measure of medial knee joint compartment load)
with these particular lateral wedge insoles.
5 Given the
established relation between knee load and risk of
structural deterioration over time,
4 it is unclear why
ourlateralwedgeinsolesdidnotreducetherateofcar-
tilageloss.Itispossibleour12monthinterventionper-
iod was not long enough to detect a disease modifying
effect.
Itisalsopossiblethatouruseoftheparticipant’sown
non-standardised shoes was a factor. Different shoe
types can influence the biomechanical and clinical
effectiveness of insoles, and in particular shoes with
heels can attenuate their effects.
43 Participants were
encouraged to wear the insoles in their usual shoes;
however, we were unable to assess adherence to this
recommendation. This was because of the difficulty
in classifying the myriad shoe types in existence and
the burden such daily recording would have imposed
on participants, with its subsequent impact on adher-
ence and retention in the study.
The amount and type of physical activity could
potentially mediate the effect of the insoles, given that
physical activity levels will influence cumulative load
at the knee. However, given that physical activity
levels as measured from either questionnaire or a ped-
ometer did not differ between the groups during the
study, this is unlikely to have influenced our results.
We included participants with painful mild to mod-
erate radiographic osteoarthritis of the medial knee
compartment and a neutral to varus knee alignment.
The participants may have had a heterogeneous
response to lateral wedge insoles depending on factors
such as radiographic severity of osteoarthritis thereby
masking our ability to find a significant treatment
effect. Indeed although case series have suggested
greater pain relief with wedge insoles in participants
with milder radiographic severity,
544 detection of a
structural effect in this group may not have been pos-
sibleinourrelativelyshortfollow-uptimeframeofone
year. Conversely, those with moderate disease who
show greater rates of structural deterioration
45 may
Table 3 |Participants reporting global improvement in symptoms and showing progression of
medial tibial and femoral cartilage defects according to insole group. Values are numbers
(percentages) unless stated otherwise
Outcome
Wedge insoles
(n=82)
Control insoles
(n=85)
Relative risk
(95 CI)
Global improvement in pain* 57 (70) 55 (64) 1.09 (0.88 to 1.35)
Global improvement in function* 46 (56) 53 (62) 0.91 (0.71 to 1.17)
Progression of medial tibial cartilage defects 13 (16) 18 (21) 0.75 (0.39 to 1.43)
Progression of medial femoral cartilage defects 16 (20) 18 (21) 0.92 (0.51 to 1.68)
*Participants rating themselves as much better or slightly better.
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vention such as lateral wedge insoles. However, when
we examined our subgroups with mild osteoarthritis
(KellgrenandLawrencegrade2) comparedwithmod-
erate osteoarthritis (Kellgren and Lawrence grade 3)
the direction of treatment effect did not differ, suggest-
ing that the lateral wedge insoles were not having a
beneficial effect in either group (data not shown).
Given that lateral wedge insoles reduce knee load, it
is often assumed that this will translate to pain relief.
Our finding that pain remained unchanged does not
supportthiscommonlyheldbelief.Althoughsomestu-
dieshaveshownapositiverelationbetweenseverityof
pain and knee load,
44647 others have found no such
relation
4849 or even an inverse one.
5051 The multiple
mechanisms contributing to the experience of pain
with knee osteoarthritis possibly explain our findings
andthoseofothers.Forexample,painisinfluencedby
amyriadofpsychosocialfactorsthatcanvarybetween
people as well as within people over time.
52 Hence it is
not surprising that favourable biomechanical changes
do not guarantee pain reduction.
The optimal dosage of insole use needed for benefi-
cial effects on pain and joint structure is not known. It
hasbeenreportedthat5-10hoursofdailyuseproduces
better symptomaticoutcomesthanless thanfive hours
or more than 10 hours of use.
53 Although in our study
the mean daily usage of 6.8 (SD 4.3) hours per day
reported in the lateral wedge insole group was less
than the 9.1 (SD 3.8) hours per day for the control
insole group, it still fell within the range of usage
recommended by a previous study.
53 Furthermore,
analysis using a hypothetical scenario with complete
adherence to the insoles also showed no significant
group differences for symptomatic or structural out-
comes, suggesting that adherence was not a factor
explaining our results.
Finally, we cannot exclude the possibility that our
non-significant results for symptoms could reflect a
typeIIerror.Painwasonlymeasuredatbaselineandat
12 months of follow-up. Knowing that pain fluctuates
in patients with osteoarthritis, we may have been able
to detect a significant insole effect had we included
more measurement time points throughout the
12 months to better estimate the average pain over
the duration of the trial.
Comparison with previous studies
Ourfindingsareinagreementwiththelimitednumber
of other randomised controlled trials that have also
failed to show the efficacy of lateral wedge insoles.
7-10
One study found that customised lateral heel wedge
insoles worn for two years were associated with a
reduced intake of non-steroidal anti-inflammatory
drugs, a secondary outcome, but did not alter pain,
stiffness, function, or joint space narrowing on radio
graphy.
910A crossovertrialfound no statisticalor clin-
icaleffectofa lateralwedgeinsolewornforsix weeks.
8
Similarly,inthemostrecentstudy,acustomisedlateral
wedge insole worn in standardised walking shoes had
nogreatereffectonpainover12monthsthananeutral
insole.
7Usingthelargestcohortofparticipantstodate,
our results concur with these clinical trials and extend
their findings by providing novel data relating to the
effects of lateral wedge insoles on structural features
seen on magnetic resonance imaging.
Strengths and weaknesses of the study
A strength of our randomised controlled trial was its
pragmatic nature whereby the intervention was exe-
cutedinamannerconsistentwithcurrentclinicalprac-
tice. Participants were provided with standardised off
the shelf wedge insoles and permitted to wear them in
their own shoes. Other strengths of our study include
the rigorous study design, incorporating blinding of
both assessor and participant, adequate statistical
power, excellent participant retention, and recruit-
ment of an osteoarthritis subgroup most likely to
Table 4 |Adverse events, comfort from and compliance with insole use, drug use, and
cointerventions according to insole group. Values are numbers (percentages) unless stated
otherwise
Measures
Wedge insoles
(n=89)
Control insoles
(n=90)
Self reported problems with insoles: 42 (47) 21 (23)
Back pain 9 (10) 1 (1)
Foot pain 32 (36) 14 (16)
Uncomfortable or difficulty fitting in shoes 15 (16) 4 (4)
Increased knee pain 2 (2) 5 (6)
Felt unstable 0 (0) 1 (1)
Mean (SD) insole comfort rating (0-10)* 3.7 (3.3) 2.0 (2.3)
Discomfort rating: (n=76) (n=87)
None 40 (53) 64 (74)
Mild 23 (30) 20 (23)
Moderate 6 (8) 2 (2)
Severe 5 (7) 1 (1)
Very severe 2 (3) 0 (0)
Mean (SD) self adherence rating (0-10)† 6.7 (3.6) 8.5 (2.4)
Drug use 47 (53) 47 (52)
Drug types:
Analgesics 27 (30) 29 (32)
Non-steroidal anti-inflammatory drugs 18 (20) 22 (24)
Cyclo-oxygenase-2 inhibitors 5 (6) 1 (1)
Glucosamine 7 (8) 7 (8)
Unspecified 6 (7) 1 (1)
Cointerventions 17 (19) 14 (16)
Cointervention type:
Physiotherapy 9 (10) 7 (8)
Exercise 3 (3) 0 (0)
Cortisone injection 2 (2) 1 (1)
Chiropractic 2 (2) 2 (2)
Acupuncture 2 (2) 0 (0)
Osteopathy 2 (2) 0 (0)
Hydrotherapy 1 (1) 0 (0)
Podiatry 1 (1) 0 (0)
Arthroscopic surgery 0 (0) 3 (3)
Total knee replacement 0 (0) 1 (1)
Other 2 (2) 2 (2)
*Based on 11 point numerical rating scale: 0=extremely comfortable and 10=extremely uncomfortable.
†Based on 11 point numerical rating scale: 0=not worn at all and 10=worn as instructed.
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tested a lateral wedge insole that had proved effective-
nessinreducingkneeloadandincorporatedasensitive
outcome measure (magnetic resonance imaging) to
assesschangeinspecificjointstructuralfeatures.Alim-
itation was the need to use a different magnetic reso-
nance imaging machine for follow-up assessment in
about 30% of the participants, which may have
increased the error within the measurements. How-
ever, our repeatability study showed that differences
in measurements between the two machines were
essentially comparable to those expected with
repeatedmeasurementstakenfromthesamemachine.
Furthermore, we also recalculated all of the primary
and secondary endpoint analyses assessing whether
the estimated intervention effect differed for partici-
pants who were scanned with one machine compared
with those scanned with both machines, but we found
noevidenceofsuchdifferences(allinteractionPvalues
>0.15). Our participants were volunteers recruited
from the community, which is a common method of
recruitment for trials of non-drug conservative inter-
ventions in knee osteoarthritis. It is possible that our
sample does not reflect fully the patients who seek
treatment from general medical practitioners. These
patients are likely to exhibit more severe disease and
thuscouldresponddifferentlytotreatmentwithlateral
wedgeinsoles.Theymayalsodifferintermsofpsycho-
social factors that are known to influence symptoms
and could affect outcomes from treatment. Our results
can only be generalised to other lateral wedge insoles
withsimilardesignfeatures.Giventhatsomeevidence
exists for subtalar strapping enhancing the effective-
nessoflateralwedgeinsoles,
5455thistypeofinsolewar-
rants further investigation.
Conclusions and practice implications
In summary, our findings showed that lateral wedge
insoles had no effect on symptoms or disease progres-
sion over 12 months in people with mild to moderate
medial knee osteoarthritis. These findings have impli-
cations for clinical practice. Given that most clinical
guidelines currently recommend lateral wedge insoles
for improving pain and function, our results and those
of other randomised controlled trials suggest that such
insoles are not beneficial for the treatment of symp-
toms.However,giventheclearbiomechanicalbenefits
of wedge insoles in reducing medial knee load, further
research is needed over a longer time frame to conclu-
sively determine the effects of lateral wedge insoles on
joint structure.
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